Sage Therapeutics Stock: Analysts Upgrade to Hold, Impact on Investors
The financial world is buzzing with the latest assessment of Sage Therapeutics (NASDAQ:SAGE), as leading research firm Wall Street Zen recently upgraded the biopharmaceutical company’s stock to…
Y-mAbs Therapeutics: Massive Short Interest Surge Sparks Market Watch
The financial landscape for Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) recently experienced a dramatic shift, marked by an unprecedented surge in short interest, capturing the attention of investors and…